Autopsy report · NCT00511121
Study of the Combination of a Tyrosine Kinase Inhibitor (STI571) and a Pegylated Human Recombinant Interferon alfa2b (PEGINTRON)
Cause of deathNo reason given
Life of this trial
- Registered 6 years 4 months after it had already started.
- 5 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- University of Bologna
- Sponsor type
- University, hospital or other
- Conditions
- Chronic Myeloid Leukemia
- Interventions
- STI571 and PEG INTRON
- Participants
- 5
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.